Pfizer’s €100m spend sees plants ‘well-placed for future’

Drugs giant, Pfizer has announced a further $130m (€100m) investment in its manufacturing facilities here, heralding a significant strengthening of its commitment to its Irish operations.

While the move is not creating any additional permanent jobs, it will significantly expand Pfizer’s Irish facilities and result in them producing more advanced and complex therapies for a number of key diseases.

Of the spend, $100m will be invested in the Grange Castle site in Dublin, with the remainder going on Pfizer’s Ringaskiddy plant, in Cork.